Vitamin D receptor presence in breast cancer tumors linked to better survival outcomes

Research identifies vitamin D receptors (VDR) in breast cancer tumors as a promising prognostic marker, linking VDR presence to tumor characteristics, survival outcomes, and potentially informing treatment strategies.

UK’s price watchdog says Lilly’s Alzheimer’s drug is too costly for broad uptake

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 24, 2024

Point Biopharma’s closely watched prostate cancer radiopharmaceutical study disappoints, Lilly again extends offer

Point Biopharma’s radiopharmaceutical prostate cancer treatment staved off disease progression or death by 3.5 months compared to hormone therapy in a closely watched Phase III

December 19, 2023

Trump is wrong in claiming full credit for lowering insulin prices

“Low INSULIN PRICING was gotten for millions of Americans by me, and the Trump Administration, not by Crooked Joe Biden. He had NOTHING to do

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.